Koninklijke Philips NV
PHG29.460USD
+0.580+2.01%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
28.02BMarktkapitalisierung
145.65KGV TTM
mehr Informationen über Koninklijke Philips NV Unternehmen
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Koninklijke Philips NV Informationen
BörsenkürzelPHG
Name des UnternehmensKoninklijke Philips NV
IPO-datumSep 18, 2009
CEOJakobs (Roy)
Anzahl der mitarbeiter67823
WertpapierartDepository Receipt
GeschäftsjahresendeSep 18
AddresseHigh Tech Campus 5
StadtEINDHOVEN
BörseNASDAQ OMX NASDAQ Basic NYSE
LandNetherlands
Postleitzahl5656 AE
Telefon31205977777
Websitehttps://www.philips.com/
BörsenkürzelPHG
IPO-datumSep 18, 2009
CEOJakobs (Roy)
Führungskräfte von Koninklijke Philips NV
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Board of Management, Chief Executive Officer
Chairman of the Board of Management, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Mr. Leandro Mazzoni
Mr. Leandro Mazzoni
Head of Investor Relations
Head of Investor Relations
--
--
Ms. Deeptha Khanna
Ms. Deeptha Khanna
Executive Vice President, Chief Business Leader Personal Health
Executive Vice President, Chief Business Leader Personal Health
--
--
Mr. Peter Loescher
Mr. Peter Loescher
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Feike Sijbesma
Mr. Feike Sijbesma
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Board of Management, Chief Executive Officer
Chairman of the Board of Management, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
North America
2.14B
42.61%
Growth geographies
1.42B
28.29%
Western Europe
1.09B
21.69%
Other Mature geographies
374.02M
7.44%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.75%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.21%
Andere
97.47%
Aktionäre
Aktionäre
Anteil
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.75%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.21%
Andere
97.47%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
4.05%
Investment Advisor/Hedge Fund
0.82%
Research Firm
0.23%
Hedge Fund
0.19%
Family Office
0.05%
Family Office
0.04%
Family Office
0.04%
Bank and Trust
0.02%
Andere
94.55%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
581
50.49M
5.31%
-12.67M
2025Q3
564
51.04M
5.37%
-17.40M
2025Q2
560
58.95M
6.20%
-8.73M
2025Q1
579
60.52M
6.54%
-8.45M
2024Q4
583
60.06M
6.49%
-29.02M
2024Q3
590
63.64M
6.83%
-28.01M
2024Q2
594
65.28M
6.99%
-29.22M
2024Q1
610
73.19M
7.82%
-21.31M
2023Q4
642
73.00M
7.79%
-18.85M
2023Q3
666
68.56M
7.24%
-21.16M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Mondrian Investment Partners Ltd.
7.91M
0.83%
+794.94K
+11.18%
Sep 30, 2025
Fiduciary Management, Inc.
7.18M
0.75%
-284.22K
-3.81%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
4.44M
0.47%
-56.61K
-1.26%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.60M
0.27%
+171.68K
+7.08%
Sep 30, 2025
Causeway Capital Management LLC
1.96M
0.21%
+107.12K
+5.79%
Sep 30, 2025
Parametric Portfolio Associates LLC
1.83M
0.19%
+109.23K
+6.35%
Sep 30, 2025
Northern Trust Global Investments
1.64M
0.17%
+121.24K
+7.99%
Sep 30, 2025
Brandes Investment Partners, L.P.
1.62M
0.17%
+87.72K
+5.73%
Sep 30, 2025
Envestnet Asset Management, Inc.
1.30M
0.14%
-51.03K
-3.78%
Sep 30, 2025
Aperio Group, LLC
1.29M
0.14%
+13.78K
+1.08%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Langar Global HealthTech ETF
5.12%
Brandes International ETF
1.99%
Brandes US Small-Mid Cap Value ETF
1.17%
ActivePassive International Equity ETF
0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
0.14%
Avantis Responsible International Equity ETF
0.12%
State Street SPDR S&P Kensho New Econ Comp ETF
0.1%
DFA Dimensional International Core Equity 2 ETF
0.09%
Avantis International Equity ETF
0.08%
Dimensional International Core Equity Market ETF
0.07%
Mehr Anzeigen
Langar Global HealthTech ETF
Anteil5.12%
Brandes International ETF
Anteil1.99%
Brandes US Small-Mid Cap Value ETF
Anteil1.17%
ActivePassive International Equity ETF
Anteil0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
Anteil0.14%
Avantis Responsible International Equity ETF
Anteil0.12%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.1%
DFA Dimensional International Core Equity 2 ETF
Anteil0.09%
Avantis International Equity ETF
Anteil0.08%
Dimensional International Core Equity Market ETF
Anteil0.07%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
